Shares down 28% in 6 months but InCred is bullish on this stock with 58% future returns - Do you own? Check target price
MAS Financial Services shares have fallen 28.22% in six months, despite reporting a 23% annual increase in second-quarter net profit to ₹115.12 crore.

Shares of MAS Financial Services Limited have declined nearly 8.32% in two weeks and around 28.22% over the last six months. Despite the decline, InCred Equities sees 58.1% upside potential in the NBFC stock given its healthy quarterly earnings, strong MSME demand, diversified lending and distribution channels.MAS Financial Services share price closed 3.69% lower on Friday, October 30. The correction in the NBFC stock came despite it reporting a 23% annual jump in its consolidated net profit and accelerated asset under management (AUM) growth in the second quarter of financial year 2026-27.MAS Financial Services share price outlookThe Gujarat-headquartered NBFC is well-positioned to post healthy growth, supported by strong MSME demand, diversified lending and distribution channels, and prudent underwriting, highlighted InCred Equities in its report.The brokerage added that NIM moderation and gradual asset quality normalisation warrant monitoring, operating efficiency and calibrated growth should profitability, as per InCred Equities.MAS Financial Services share price recommendationThe brokerage maintained its ‘Add’ rating for the stock with a target price of ₹400 per share.
“We maintain ADD rating on the stock with a target price of Rs400, valuing it at 1.9x FY28F BVPS and 13x FY28F EPS. Downside risks include slower-than-expected growth, sustained margin pressure and material deterioration in asset quality,” read the brokerage report.MAS Financial Services share price trendThe stock closed 3.69% lower at ₹244.10 per share on BSE with a market capitalisation of ₹4,429.28 crore on Friday. Its share price value has 28.22% in six months, 20.80% in one month and around 14.58% in two years.Q2 result recapMAS Financial Services reported a net profit of ₹115.12 crore in the second quarter of financial year 2026-27. Its net profit stood at ₹91.43 crore in the same quarter in the previous financial year.
Related Stories

Laurus Labs, Gland Pharma, Piramal, Divi's Labs: 4 drug manufacturing stocks rally up to 89% in 6 months - Upside ahead?
Pharma stocks, particularly CDMO companies, have surged over the past six months amid optimism about quarterly results. Laurus Labs led with an 88.64% gain, followed by Gland Pharma at 80.36%, Divi’s Laboratories at 72.35% and Piramal Pharma at 38.65%.

NMDC Steel Q2 Results: Firm swings to black, posts ₹61 crore profit; margin expands
NMDC Steel returned to profitability in Q2 FY27, reporting a net profit of ₹61 crore against a loss of ₹115 crore a year ago. Revenue increased 11%, while EBITDA rose to ₹462.2 crore and the margin expanded to 12.3%.

Oil India dividend, Q2 results 2026: PSU giant announces interim payout as profit more than doubles - Check record date
Oil India’s standalone Q2 FY27 net profit more than doubled year over year to ₹2,259.42 crore, while revenue rose to ₹8,071.33 crore. The board approved an interim dividend of ₹7 per share, with November 20 as the record date.
